PMDI
Psychemedics Corp
$2.49
+0.00 (+0.00%)
At close · Jul 2
Market Cap
$15.21M
Shares
6,109,502
Price & Indicators
Indicators
Price
Panels
Event markers
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$2.49
Open$2.49
Day$2.49–2.49
52W$1.33–2.70
Avg vol 30d683
Short int5K · 0.1% float · 52.8d
Short vol12%
Last earningsNov 12, 2024
DataJan 2020–Jul 2026
Filing10-K · Mar 24
Equibles Rating
blended score · not investment advice
Overall
Neutral
Technical · trend & momentum
Buy
◦
50 / 200-day cross
no cross
+
Price vs 200-day avg
+28% above
+
Price vs 50-day avg
+10% above
−
RSI (14)
79 · overbought
+
MACD trend
positive
◦
52-week position
85% · mid-range
Sentiment · smart money
Bearish
◦
Trend (MA cross)
50d $2 › 200d $2 — 50d above 200d
◦
Institutional flow
0% holders QoQ
◦
Insider flow
No net insider activity over 90 days
−
Short interest
0.08% of float · ▲ +2.7% MoM · 52.8 days cover
◦
Volume signal
Volume near normal
◦
Institution breadth
1 holders — near 1-yr low, contrarian setup
Fundamentals
Weak
◦
Revenue growth
+2% Y/Y
−
Gross margin
18%, contracting
−
EPS growth
−58% Y/Y
+
Free cash flow
$878.0K
◦
Balance sheet
net debt $1.2M
Blended from price, positioning & fundamentals · daily-close · not investment advice.
Up next
FQ3-26 quarter ends
~Sep 30, 2026
Est
filed Mar 24, 2025
Technicals
trend & momentum for long-term holders Buy
50 / 200-day cross
no cross
Neutral
Price vs 200-day avg
+28% above
Bullish
Price vs 50-day avg
+10% above
Bullish
RSI (14)
79 · overbought
Bearish
MACD trend
positive
Bullish
52-week position
85% · mid-range
Neutral
Market signals — smart money & positioning
Bearish · 1 of 6
Trend (MA cross)
No cross
50d $2 › 200d $2 — 50d above 200d
Institutional flow
Flat
0% holders QoQ
Insider flow
Flat
No net insider activity over 90 days
Short interest
Rising
0.08% of float · ▲ +2.7% MoM · 52.8 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr low
1 holders — near 1-yr low, contrarian setup
Price context
position in its 52-week range
52-wk low $1
Now $2 · 85%
52-wk high $3
vs 200-day avg +28%
vs 50-day avg +10%
Illustrative technical + ownership context — a signal mix, not investment advice.
Versus peers
Diagnostics & Research — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
PMDI
this stock
Psychemedics Corp
|
$15.21M | +55.6% | +1.8% | — | 0.1% |
|
TMO
Thermo Fisher Scientific Inc.
|
$190.46B | -9.6% | +0.4% | 28.0 | 1.2% |
|
DHR
Danaher Corp /De/
|
$140.09B | -13.4% | +8.5% | 38.2 | 1.6% |
|
IDXX
Idexx Laboratories Inc /De
|
$44.00B | -17.5% | +10.4% | 41.0 | 2.7% |
|
NTRA
Natera, Inc.
|
$40.00B | +21.9% | -2.8% | — | 3.0% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Financials
Filings
Earnings & Events
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| PMDI | +13.2% | +13.2% | +66.0% | +0.0% | +55.6% |
| SPY | +1.4% | -1.3% | +8.0% | -0.3% | +9.2% |
| vs SPY | +11.8% | +14.4% | +58.0% | +0.3% | +46.4% |